发明申请
- 专利标题: 2'-CHLORO NUCLEOSIDE ANALOGS FOR HCV INFECTION
- 专利标题(中): 用于HCV感染的2'-氯代核苷类似物
-
申请号: US14047862申请日: 2013-10-07
-
公开(公告)号: US20140099283A1公开(公告)日: 2014-04-10
- 发明人: Gilles GOSSELIN , Christophe Claude PARSY , Francois-Rene ALEXANDRE , Houcine RAHALI , Jean-Francois GRIFFON , Julien MILHAU , Dominique SURLERAUX , Cyril B. DOUSSON , Claire PIERRA , Adel M. MOUSSA , Benjamin Alexander MAYES
- 申请人: Idenix Pharmaceuticals, Inc. , Universite Montpellier 2 Sciences Et Techniques , Centre National De La Recherche Scientifique
- 主分类号: C07H19/10
- IPC分类号: C07H19/10 ; A61K45/06 ; A61K38/21 ; C07H19/20 ; A61K31/7076 ; A61K31/708 ; C07H19/14 ; A61K31/7064 ; C07H19/12 ; A61K31/706 ; A61K31/7068 ; A61K31/7072 ; C07H19/16
摘要:
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 2′-chloro nucleosides according to Formula 2001: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form or polymorphic form thereof, wherein B, Z and PD are as described herein.
公开/授权文献
- US10513534B2 2′-chloro nucleoside analogs for HCV infection 公开/授权日:2019-12-24
信息查询
IPC分类: